Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Telomir Pharmaceuticals, Inc. - Common Stock
(NQ:
TELO
)
5.930
-0.490 (-7.63%)
Streaming Delayed Price
Updated: 12:47 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
55,513
Open
6.520
Bid (Size)
5.910 (1)
Ask (Size)
5.990 (1)
Prev. Close
6.420
Today's Range
5.801 - 6.520
52wk Range
3.110 - 20.72
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO), Science of Longevity Featured in Upcoming Episode of “Health Uncensored with Dr. Drew”
September 27, 2024
Via
Investor Brand Network
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
September 26, 2024
Via
ACCESSWIRE
Performance
YTD
+18.60%
+18.60%
1 Month
+19.56%
+19.56%
3 Month
+39.53%
+39.53%
6 Month
+8.61%
+8.61%
1 Year
+18.60%
+18.60%
More News
Read More
Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs
September 05, 2024
Via
News Direct
BioMedNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific Advisor
September 04, 2024
Via
Investor Brand Network
Exposures
Product Safety
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
August 20, 2024
Via
ACCESSWIRE
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
September 04, 2024
Via
ACCESSWIRE
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q2 2024
August 13, 2024
Via
InvestorPlace
From Pets To Humans, Telomir Pharmaceuticals (NASDAQ: TELO) Holds The Key To Extending Life, Reversing Aging
May 31, 2024
Via
News Direct
TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q1 2024
May 13, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 12, 2024
Via
Benzinga
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 15, 2024
Via
Benzinga
Why AppLovin Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
February 15, 2024
Via
Benzinga
Cisco Issues Weak Outlook, Joins Fastly, Herbalife And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
February 11, 2024
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
